
Narayana Hrudayalaya Q2 Results 2025 Highlights: Net Profit Rises by 30.07% & Revenue Up 20.28% YoY
Posted by : sachet | Tue Nov 25 2025

Click and Sign Up to Get Live Updates on Q2 Results
Narayana Hrudayalaya Q2 Results FY26: During Q2 FY26, Narayana Hrudayalaya’s profit increased 30.07% YoY, while revenue increased by 20.28% YoY. The company posted robust numbers, with Q2 PAT at ₹258.37 crores and revenue at ₹1,643.79 crores. Narayana Hrudayalaya announced its Q2 results on 14th November 2025.
Narayana Hrudayalaya Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30th Sep 2025 | 30 Sept 2024 | |
| Revenue from Operations | ₹1,643.79 | ₹1,366.68 |
| Profit Before Tax (PBT) | ₹426.49 | ₹332.33 |
| Profit After Tax (PAT) | ₹258.37 | ₹198.63 |
(Figures in crores)
Narayana Hrudayalaya Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30th Sept 2025 | 30th Sept 2024 | |
| Revenue from Operations | ₹1,019.17 | ₹934.29 |
| Profit Before Tax (PBT) | ₹246.14 | ₹195.72 |
| Profit After Tax (PAT) | ₹137.88 | ₹105.53 |
(Figures in crores)
Narayana Hrudayalaya Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- Narayana Hrudayalaya clocked Q2 FY26 consolidated revenue of ₹1,643.79 crores vs ₹1,366.68 crores.
- On the profit front, Narayana Hrudayalaya earned a consolidated PAT of ₹258.37 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹198.63 crore.
- According to the consolidated figures, Narayana Hrudayalaya’ quarterly PAT increased by 30.07% YoY, while revenue increased by 20.28%.
- Narayana Hrudayalaya clocked Q2 FY26 standalone revenue of ₹1,019.17 crores vs ₹934.29 crores.
- On the profit front, Narayana Hrudayalaya earned a standalone PAT of ₹137.88 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹105.53 crore.
- According to the standalone figures, Narayana Hrudayalaya’ quarterly PAT increased by 30.66% YoY, while revenue increased by 9.08%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Narayana Hrudayalaya Share Price Performance
On the opening bell on 25th November 2025, Narayana Hrudayalaya shares opened at ₹1,980.90 per share. However, the initial gains have since eroded, and Narayana Hrudayalaya shares are currently trading at ₹1,956.90 per share, which is lower than the opening price.
Considering the long-term achievements, Narayana Hrudayalaya shares have yielded returns of approximately 55.84% over the past years, and 5-year returns stand at 406.22%. Over the maximum timeframe, Narayana Hrudayalaya shares delivered a 497.43% return to investors.
What Analysts Expect Post Q2 Results?
Following Narayana Hrudayalaya’ robust Q2 results, analysts expect its share price to rise. According to analysts, Narayana Hrudayalaya’ share price is expected to reach ₹2,045.60 per share in the coming year; however, in a downturn, it could fall to ₹1,939.40 per share. However, one must ignore stock market volatility and invest in Narayana Hrudayalaya after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY
Inspira Enterprise India IPO Details: Everything You Should Know about
Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here
Related Posts
Valor Estate Q2 Results 2025 Highlights: Net Profit Surged by 108.81% & Revenue Up 3,833.66% YoY
SKF India Q2 Results 2025 Highlights: Net Profit Rises by 12.00% & Revenue Up 5.21% YoY
Max Healthcare Institute Q2 Results 2025 Highlights: Net Profit Surged by 74.34% & Revenue Up 25.07% YoY
Sudeep Pharma IPO Allotment Status Check Online: GMP, Subscription, Price, and More

